Versiti, a national leader in blood health innovation, has announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. Further expanding Versiti’s clinical trial expertise and service offering, Quantigen provides a range of services supporting preclinical and clinical research as well as clinical diagnostics. The Quantigen team specializes in assay development, biomarker validation, and diagnostic regulatory filings for a wide range of methods and disease states. The Quantigen team is particularly proud of ongoing partnerships with NGOs to adapt existing diagnostic technologies for use in lower- and middle-income countries to address significant unmet diagnostic and health needs in these communities.
Read the full article: Versiti Acquires Indiana-Based Quantigen //
Source: https://www.prnewswire.com/news-releases/versiti-acquires-indiana-based-quantigen-301873083.html